Tech Company Financing Transactions
Neuronascent Funding Round
Neuronascent secured a $100 thousand financing round on 6/30/2007. Backers included TEDCO.
Transaction Overview
Company Name
Announced On
6/30/2007
Transaction Type
Venture Equity
Amount
$100,000
Round
Undisclosed
Investors
TEDCO (Christine Copple)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
6030 Day Break Cir. A150 - PMB244
Clarksville, MD 21029
USA
Clarksville, MD 21029
USA
Phone
Website
Email Address
Overview
Neuronascent is focused on the discovery and development of therapies for Alzheimer's disease, stroke and depression based on the science of neurogenesis that.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Judith Kelleher
Chief Operating Officer
Kenneth Narducy
Browse more venture capital transactions:
Prev: 6/30/2007: Insperity venture capital transaction
Next: 6/30/2007: Marillion Pharmaceuticals venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs